Literature DB >> 23608078

Words of wisdom. Re: Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1.

Keith R Solomon1, Emma H Allott, Michael R Freeman, Stephen J Freedland.   

Abstract

Entities:  

Year:  2013        PMID: 23608078      PMCID: PMC4051300          DOI: 10.1016/j.eururo.2013.03.017

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  7 in total

1.  Prostatic cholesterol metabolism: regulation and alteration.

Authors:  C P Schaffner
Journal:  Prog Clin Biol Res       Date:  1981

Review 2.  Cholesterol and prostate cancer.

Authors:  Kristine Pelton; Michael R Freeman; Keith R Solomon
Journal:  Curr Opin Pharmacol       Date:  2012-07-21       Impact factor: 5.547

3.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

4.  Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.

Authors:  Carlos G Leon; Jennifer A Locke; Hans H Adomat; Susan L Etinger; Alexis L Twiddy; Rachel D Neumann; Colleen C Nelson; Emma S Guns; Kishor M Wasan
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

5.  Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.

Authors:  A J C Pommier; G Alves; E Viennois; S Bernard; Y Communal; B Sion; G Marceau; C Damon; K Mouzat; F Caira; S Baron; J M A Lobaccaro
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

6.  Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.

Authors:  Steven E Trasino; Young S Kim; Thomas T Y Wang
Journal:  Mol Cancer Ther       Date:  2009-06-16       Impact factor: 6.261

7.  The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network.

Authors:  Jayoung Kim; Dolores Di Vizio; Taek-Kyun Kim; Jonghwan Kim; Minjung Kim; Kristine Pelton; Steven K Clinton; Tsonwin Hai; Daehee Hwang; Keith R Solomon; Michael R Freeman
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

  7 in total
  3 in total

1.  Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.

Authors:  Lujing Wang; Ahmad Abdel Fat Shannar; Renyi Wu; Pochung Chou; Md Shahid Sarwar; Hsiao-Chen Kuo; Rebecca Mary Peter; Yujue Wang; Xiaoyang Su; Ah-Ng Kong
Journal:  Mol Nutr Food Res       Date:  2022-04-28       Impact factor: 6.575

2.  ATP-binding cassette transporter A1: A promising therapy target for prostate cancer.

Authors:  Ting Xiong; Gang Xu; Xue-Long Huang; Kai-Qiang Lu; Wei-Quan Xie; Kai Yin; Jian Tu
Journal:  Mol Clin Oncol       Date:  2017-11-15

3.  MiR-200b-3p Functions as an Oncogene by Targeting ABCA1 in Lung Adenocarcinoma.

Authors:  Keqiang Liu; Weiqiang Zhang; Jian Tan; Jingbo Ma; Jing Zhao
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.